Skip to main content

. 1996 Dec;55(12):935–936. doi: 10.1136/ard.55.12.935

Serum and synovial fluid levels of interleukin-5 in a patient with eosinophilic fasciitis.

K Nishiya, N Tanimoto, K Hashimoto, M Hashizume, A Tominaga

PMCID: PMC1010352 PMID: 9014593

935

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Barnes L., Rodnan G. P., Medsger T. A., Short D. Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol. 1979 Aug;96(2):493–518. [PMC free article] [PubMed] [Google Scholar]
Hirashima M., Ueno M., Higuchi S., Matsumoto T., Sakata K. M., Matsumoto R., Adachi M. Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils. Lymphokine Cytokine Res. 1992 Dec;11(6):331–338. [PubMed] [Google Scholar]
Kopf M., Brombacher F., Hodgkin P. D., Ramsay A. J., Milbourne E. A., Dai W. J., Ovington K. S., Behm C. A., Köhler G., Young I. G. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996 Jan;4(1):15–24. doi: 10.1016/s1074-7613(00)80294-0. [DOI] [PubMed] [Google Scholar]
Matsumoto R., Ando M., Kohrogi H., Araki S., Takatsu K. Interleukin-5 levels of pleural fluid and serum samples in a patient with PIE syndrome. Chest. 1992 Oct;102(4):1296–1297. doi: 10.1378/chest.102.4.1296. [DOI] [PubMed] [Google Scholar]
Meeker T. C., Hardy D., Willman C., Hogan T., Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood. 1990 Jul 15;76(2):285–289. [PubMed] [Google Scholar]
Rosenthal J., Benson M. D. Diffuse fasciitis and eosinophilia with symmetric polyarthritis. Ann Intern Med. 1980 Apr;92(4):507–509. doi: 10.7326/0003-4819-92-4-507. [DOI] [PubMed] [Google Scholar]
Sanderson C. J., Campbell H. D., Young I. G. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev. 1988 Feb;102:29–50. doi: 10.1111/j.1600-065x.1988.tb00740.x. [DOI] [PubMed] [Google Scholar]
Tominaga A., Takaki S., Koyama N., Katoh S., Matsumoto R., Migita M., Hitoshi Y., Hosoya Y., Yamauchi S., Kanai Y. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med. 1991 Feb 1;173(2):429–437. doi: 10.1084/jem.173.2.429. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES